Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q13153: Variant p.Tyr131Cys

Serine/threonine-protein kinase PAK 1
Gene: PAK1
Feedback?
Variant information Variant position: help 131 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Tyrosine (Y) to Cysteine (C) at position 131 (Y131C, p.Tyr131Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from large size and aromatic (Y) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In IDDMSSD; gain of function; enhanced PAK1 kinase activity and significantly reduced homodimerization. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 131 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 545 The length of the canonical sequence.
Location on the sequence: help NITKSEQKKNPQAVLDVLEF Y NSKKTSNSQKYMSFTDKSAE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 2 – 545 Serine/threonine-protein kinase PAK 1
Region 70 – 140 Autoregulatory region
Modified residue 115 – 115 Phosphoserine
Modified residue 131 – 131 Phosphotyrosine
Modified residue 142 – 142 Phosphotyrosine
Modified residue 144 – 144 Phosphoserine; by autocatalysis
Modified residue 149 – 149 Phosphoserine
Helix 121 – 135



Literature citations
Activating mutations in PAK1, encoding p21-activated kinase 1, cause a neurodevelopmental disorder.
Harms F.L.; Kloth K.; Bley A.; Denecke J.; Santer R.; Lessel D.; Hempel M.; Kutsche K.;
Am. J. Hum. Genet. 103:579-591(2018)
Cited for: INVOLVEMENT IN IDDMSSD; VARIANTS IDDMSSD CYS-131 AND CYS-429; CHARACTERIZATION OF VARIANTS IDDMSSD CYS-131 AND CYS-429; FUNCTION; HOMODIMERIZATION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.